A, Proportion of variants detected in the MMR genes.

Slides:

Advertisements

Similar presentations

Colon Cancer The life time risk of developing Colon Cancer in the United States in one in sixteen. This means 144,000 new cases a year accounting for.

Advertisements

Clinical background: Patient RM, YoB 1966 Her family were originally referred because of a history of breast and ovarian cancer. BRCA testing found a missense.

Suggestions for PMS2 best practice Jenny Simmonds

Comprehensive IHC Screening for Lynch Syndrome: What You Need to Know Andrea Lewis, MS, CGC January 14, 2010.

An Accurate Genetic Model for Predicting the Carrier Status of mmr-gene Mutations Fabio Marroni 1, Piero Benatti 2, Mariapina Montera 3, Daniela Barana.

Tumour Analysis-Lynch Syndrome Dr Alan Donaldson Consultant in Clinical Genetics Bristol.

Immunology and the Lynch Syndrome

Counseling Patients About Germline BRCA Mutations

A, baseline and 4-week PET scan from patient 2 (MET c

Fig. 1 Number of somatic mutations in representative human cancers, detected by genome-wide sequencing studies. Number of somatic mutations in representative.

Genomic alterations in breast cancer cell line MDA-MB-231.

PD-1 and LAG-3 expression in MSI and MSS colorectal cancer specimens.

Dihydromyricetin decreases the sphere formation through downregulation of Sox2 in human osteosarcoma. Dihydromyricetin decreases the sphere formation through.

Representative 3-generation pedigrees for serous cancer probands suggestive of inherited cancer susceptibility. Representative 3-generation pedigrees for.

Tumor intrinsic subtype is reflected in cancer-adjacent tissue.

Ajay Goel, Takeshi Nagasaka, Jennifer Spiegel, Richard Meyer, Warren E

Noralane M Lindor Clinical Gastroenterology and Hepatology

Inherited DNA-Repair Defects in Colorectal Cancer

Figure 3 Examples of gene expression heterogeneity

Immunology and the Lynch Syndrome

Alterations related to androgen signaling.

ROC curve for separating advanced stages (advanced BE and EA) versus early stages (BE or BE instability) using total genome-wide LOH [area under the curve.

Number of 0.5-Mb windows with chromosome lesions that reached statistical significance across patients in early (BE early and BE instability) and late.

Colorectal cancer at a young age

Quantification of MHC-I, β2m, and T-cell subsets.

A, SSA/P is seen in the right colon (outlined by arrows) at colonoscopy. A, SSA/P is seen in the right colon (outlined by arrows) at colonoscopy. Note.

Inherited DNA-Repair Defects in Colorectal Cancer

Distinct molecular and clinical correlates of H3F3A mutation subgroups

TFAP2A is highly expressed in nasopharyngeal carcinoma cells and tumor tissues. TFAP2A is highly expressed in nasopharyngeal carcinoma cells and tumor.

BRCA1 promoter methylation detected in the peripheral blood and corresponding tumor. BRCA1 promoter methylation detected in the peripheral blood and corresponding.

Correlation of RSPO expression to LGR5 expansion in gastric cancer.

IL32 is highly expressed in mycosis fungoides lesional skin.

Frequent alterations identified and potential actionability.

Effects of maternal exposure during pregnancy to tap water (control), LIM, or HIM on offspring tumor incidence (% rats with tumors; A), tumor multiplicity.

Heat map of genes for which CR significantly altered expression versus AL. Cluster analysis of genes significantly changed by the CR intervention compared.

Immune signatures of patients with short-, medium-, and long-term survival. Immune signatures of patients with short-, medium-, and long-term survival.

Correlation between serum visfatin concentrations and the clinical stage (A) and tumor size (B, C) of HCCs. A and B, the correlations were determined by.

M-Wnt and E-Wnt cells cluster tightly with claudin-low and basal-like breast tumors, respectively, by microarray analysis. M-Wnt and E-Wnt cells cluster.

Dose-dependent effect of IP6 feeding on molecules associated with tumor sustenance and glucose transportation in dorsolateral prostate of TRAMP mice. Dose-dependent.

Predictive value of the FGFR3 mutation assay increases with multiple consecutive FGFR3-positive urine samples. Predictive value of the FGFR3 mutation assay.

FGFR3 mutation analysis of a selection of urine samples from patients included with an FGFR3-mutant (MT) tumor. FGFR3 mutation analysis of a selection.

The I1307K APC gene variant was identified using primers designed to detect the I1307K. The I1307K APC gene variant was identified using primers designed.

Overview of TIMER modules on the website.

ALDH1A3 expression levels are inversely correlated with the survival of patients with resectable mass-forming and advanced cholangiocarcinoma, respectively.

Activation of mTOR signaling (increased phosphorylated S6 ribosomal protein) and loss of inhibition of IRS-1 in human endometrial carcinomas. Activation.

Survival risk prediction analysis and application of the metastasis gene signature. Survival risk prediction analysis and application of the metastasis.

Kaplan-Meier survival analysis of p53 mutation in the overall breast tumor series. Kaplan-Meier survival analysis of p53 mutation in the overall breast.

HMQ1611 inhibited breast tumor growth in mice.

Representative images demonstrating LOH in breast cancer patients’ paired BM aspirate and primary tumors (T) at D14S62, D14S51, and D8S321, respectively.

Location of the ER mutations and frequencies per cohort.

The effect of a DIO regimen ± EPA+DHA supplementation on tumor growth.

Fig. 1 Number of somatic mutations in representative human cancers, detected by genome-wide sequencing studies. Number of somatic mutations in representative.

Enhanced expression of Cap43 gene by nickel in breast cancer cell lines. Enhanced expression of Cap43 gene by nickel in breast cancer cell lines. Expression.

Frequently mutated genes in colorectal cancer.

The influence of diverse genotypes of rs on the expression of MAVS (A), IFNβ (B), in PBMCs of healthy individuals. The influence of diverse genotypes.

Reduced expression of the tumor suppressor PTEN occurs in tumors with both squamous cell and adenocarcinoma histology. Reduced expression of the tumor.

Validation of NAA's cancer specificity in lung cancer.

A, Proportion for different in silico predictions at the RNA level.

A and B, linearity of the preamplification step shown by a similar expression pattern of ERα mRNA in four breast tumor samples pre– and post–linear amplification.

Individuals affected with cancer included in the Lynch syndrome are colored. Individuals affected with cancer included in the Lynch syndrome are colored.

Regression analysis showing the positive correlation between number of months since the prior chemotherapy regimen (X axis) and the difference between.

Defining the eTME genes.

Correlations between APOBEC expression and immune cell markers across 22 cancer types. Correlations between APOBEC expression and immune cell markers across.

Venn diagram showing the overlap of PD-L1 overexpression, MSI-NGS–high, and TML-high in all gastrointestinal tumors, with all three markers tested (N =

AXL-on tumors are heterogeneous for AXL expression and EdU incorporation. AXL-on tumors are heterogeneous for AXL expression and EdU incorporation. A,

Recruitment of CD8+, CD4+, and Foxp3+ cells into oral lesions in response to anti–PD-1 treatment. Recruitment of CD8+, CD4+, and Foxp3+ cells into oral.

A, study design for measuring the feasibility, concordance, and accuracy of a plasma-based cfDNA sequencing test compared with biopsy-based sequencing.

TME characteristics of TCGA-STAD subtype and cancer somatic genome.

CONSORT diagram. a, 5 had a major treatment violation (3 refused and 2 received wrong treatment) but were included in the analyses; b, 4 had a major treatment.

GSN and DNMT1 expression are inversely correlated in a pattern associated with patient survival. GSN and DNMT1 expression are inversely correlated in a.

Presentation transcript:

A, Proportion of variants detected in the MMR genes. A, Proportion of variants detected in the MMR genes. B, Proportion of different types of variants in MMR genes. C, Proportion patients with positive family history criteria per MMR gene mutated. D, Proportion of tumors displaying MSS, MSI-L and MSI-H per MMR gene. E, Correlation between loss of IHC expression and gene variant location. Abbreviations: Ams, Amsterdam criteria; Beth, Bethesda criteria; Ams/Beth, more than one family with the same variant with a different criteria; MSS, microsatellite stable, MSI-L, microsatellite instability-low; MSI-H, microsatellite instability-high. Ester Borras et al. Cancer Prev Res 2017;10:580-587 ©2017 by American Association for Cancer Research